NCR-102

N/A

Report date: 2025/09/16 20:00:07

Base Information

Drug NameNCR-102
Drug Alias NameNCR102NCR-102
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > iPSC-derived
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhongsheng Traceability (Guangzhou) Biotechnology Co LtdAnhui Nuwacell Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhongsheng Traceability (Guangzhou) Biotechnology Co LtdAnhui Nuwacell Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGraft vs Host Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A